Metabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to public health and escalating the burden on health care resources. Characterized by the ...
Apr 3, 2024
0
24
People with opioid use disorder who have hepatitis C virus (HCV) were twice as likely to be successfully treated and cured from HCV if they received facilitated telemedicine treatment at their opioid treatment program (OTPs) ...
Apr 3, 2024
0
10
A research team from the Paul-Ehrlich-Institut has gained important insights into the role of the human guanylate-binding protein 1 (GBP1) in hepatitis C virus infection. Their results show that GBP1 performs a previously ...
Mar 26, 2024
0
9
Developing improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology, and in a recent landmark study, published in Hepatology, researches from Flinders ...
Apr 11, 2024
0
0
Chronic infection with the hepatitis B virus (HBV) causes progressive liver problems, and eradication of the virus remains a formidable challenge.
Apr 10, 2024
0
0
More than 3,500 people die from hepatitis viruses every day and the global toll is rising, the World Health Organization warned on Tuesday, calling for swift action to fight the second-largest infectious killer.
Apr 9, 2024
0
0
New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday.
Apr 3, 2024
0
17
Canada will not reach the original World Health Organization's (WHO) target of eliminating the hepatitis C virus (HCV) by 2030 and lags in comparison to other developed countries, a new study led by researchers at the University ...
Apr 15, 2024
0
3
